Uploaded August 2026 | Updated September 2026, 2 weeks ago
Colossal Biosciences hit a $10.2 billion valuation on a promise to bring back the woolly mammoth by 2028, but its backers, from Paris Hilton and Tom Brady to George R.R. Martin and the producer of Jurassic World, aren't really betting on de-extinction.
*Want to spot the real money-makers inside a business?* clickhubspot.com/6g4s
The real play is the synthetic biology, gene editing, and ancient DNA infrastructure the company built to revive extinct animals like the woolly mammoth, dodo bird, and Tasmanian tiger - breakthroughs already linked to a possible key to how cancer cells self-destruct.
Here's how a startup reviving prehistoric animals became one of the most valuable biotech companies on Earth, and why its earliest investors were storytellers, not scientists.
Get the 5-minute newsletter keeping 2M+ innovators in the loop: thehustle.co/join-free-2
Timestamps
0:00 Yes, de-extinction is a thing
0:45 Colossal Biosciences' $10.2B valuation
1:58 What makes de-extinction possible?
2:17 The father of synthetic biology
3:45 Where mammoths used to thrive
4:37 What bringing the mammoth back actually means
5:03 What kind of company is Colossal Biosciences, really?
6:47 “Not really a mammoth” and real value
7:35 The CIA is investing in de-extinction, too
8:06 Peto’s paradox and the potential of curing cancer
9:37 The broader implications of bringing back woolly mammoths
#DeExtinction #WollyMammoth #AncientDNA
Colossal Biosciences hit a $10.2 billion valuation on a promise to bring back the woolly mammoth by 2028, but its backers, from Paris Hilton and Tom Brady to George R.R. Martin and the producer of Jurassic World, aren't really betting on de-extinction.
*Want to spot the real money-makers inside a business?* clickhubspot.com/6g4s
The real play is the synthetic biology, gene editing, and ancient DNA infrastructure the company built to revive extinct animals like the woolly mammoth, dodo bird, and Tasmanian tiger - breakthroughs already linked to a possible key to how cancer cells self-destruct.
Here's how a startup reviving prehistoric animals became one of the most valuable biotech companies on Earth, and why its earliest investors were storytellers, not scientists.
Get the 5-minute newsletter keeping 2M+ innovators in the loop: thehustle.co/join-free-2
Timestamps
0:00 Yes, de-extinction is a thing
0:45 Colossal Biosciences' $10.2B valuation
1:58 What makes de-extinction possible?
2:17 The father of synthetic biology
3:45 Where mammoths used to thrive
4:37 What bringing the mammoth back actually means
5:03 What kind of company is Colossal Biosciences, really?
6:47 “Not really a mammoth” and real value
7:35 The CIA is investing in de-extinction, too
8:06 Peto’s paradox and the potential of curing cancer
9:37 The broader implications of bringing back woolly mammoths
#DeExtinction #WollyMammoth #AncientDNA
